Nanotis corporation

Problem: Existing testing technologies, such as PCR and immunochromatography test kits, face two major challenges: 1) the absence of a diagnostic test that accurately, quickly, and affordably screens large populations, and 2) the lack of immediate transmission of test results, hindering timely public health responses during outbreaks. Solution: The NANOTIS method is an innovative platform technology that introduces the concept of concentration by dielectrophoresis into detection systems for the first time globally. It combines high sensitivity with saliva, ultra-rapid results, and efficient data integration, targeting not only infectious diseases but also a variety of biological particles in the future. Target Markets: Clinics/Hospitals, Individuals, Facilities, Governments Looking for business opportunities in: Investor, Mentor, Funding, University, Corporation Technology Readiness Level: TRL 1-2 Scientific Validation Contact info: Lisa Sakashita lisa@nanotis.net